We will use cookies and other information to optimize your experience. By continuing to browse, you consent to our use. For details, please read
Privacy Policy
×
Gongwin Biopharm Co., Ltd.
Language
繁體中文
English
About Us
Company Profile
History
Our Team
Partnership
News&Media
Press Release
Recent Activity
Events
Pipeline
Products
PTS302 NSCLC-SMAO
PTS100 HCC
PTS-02 ACC
PTS500 MPE
R & D
Core Technology
Mechanism of Action
R & D Center
Patent Portfolio
Published Paper
Investors
Financial information
Company annual report
Financial report
Monthly revenue
Legal person briefing
Corporate Governance
Corporate governance structure
Board of Directors
Committee
Internal audit
Company regulations
Other corporate governance information
Shareholder area
Shareholders' meeting
Dividend distribution
Material message
Stock price message
Investor Relations Contact Window
Stock agency
Interest relationship
Interested parties communicate with the company
Join Us
Contact
Home
News&Media
Press Release
05
2018.11
2018-11-05 Gongwin-KY cancer new drug PT...
Accepted by the internationally renowned journal Frontiers in Pharmacology.....Read More
11
2018.10
2018-10-11 China Drug Certification Revi...
PTS302 is Worthy of Attention and Optimistic Market Prospects are anticipated.....Read Mo...
08
2018.08
2018-08-08 KY liver cancer new drug PTS1...
KY liver cancer new drug PTS100 clinically locked liver cancer patients accelerated phase ...
25
2018.06
2018-06-25 Taking advantage of China CFD...
Taking advantage of China CFDA priority approval policy.....Read More
02
2018.05
2018-05-02 KY completed 297 million yuan...
KY completed 297 million yuan in cash increase the net value.....Read More
28
2018.02
2018-02-28 Gongwin-KY to Co-Operate with...
KY liver cancer new drug PTS100 and Taiwan University Hospital.....Read More
1
2
1
2
繁體中文
English
Language
繁體中文
English
About Us
Company Profile
History
Our Team
Partnership
News&Media
Press Release
Recent Activity
Events
Pipeline
Products
PTS302 NSCLC-SMAO
PTS100 HCC
PTS-02 ACC
PTS500 MPE
R & D
Core Technology
Mechanism of Action
R & D Center
Patent Portfolio
Published Paper
Investors
Financial information
Company annual report
Financial report
Monthly revenue
Legal person briefing
Corporate Governance
Corporate governance structure
Board of Directors
Committee
Internal audit
Company regulations
Other corporate governance information
Shareholder area
Shareholders' meeting
Dividend distribution
Material message
Stock price message
Investor Relations Contact Window
Stock agency
Interest relationship
Interested parties communicate with the company
Join Us
Contact
